Multiple sclerosis (MS) is a chronic and progressive disease of the central nervous system (
1), which is more common in young adults from 20 to 40 years old (
2-
5), and is more widespread in women than in men (
3-
5). This disease can cause blurred and double vision, muscle weakness, impaired balance and coordination, increased sensations of depression (average to severe), cognitive impairment, pain, forgetfulness, a lack of concentration, fatigue, tremors, dizziness, impaired bowels, and bladder and sexual dysfunctions in affected people (
4,
6). The average annual death rate in MS patients is 2.6%, causing thousands of deaths in all age groups, while the mortality rate due to the direct effects of MS has been reported as 900/100,000 deaths (
6). The cause of such a high mortality rate is unknown; however, studies have shown that genetic and environmental factors play important roles in the pathogenesis of this disease (
7). The prognosis of MS is largely unknown, and patients suffer from both psychiatric disorders and physical experiences of the disease (
8).
The incidence and prevalence of MS varies considerably around the world (
9). In Iran, the prevalence of MS varies from 15 to 30 per 100 thousand people (
10), which continues to grow (
11). The disease process of MS patients increases the necessity of considering the issues in Iran; for example, the medical problems of the patient create a set of mental and physical problems that may affect most of the daily activities of a person, such as clothing, bathing, and taking care of themselves. These problems cause a decrease in individual independence, feelings of inadequacy, and a decrease in the quality of life. Approximately 75 to 95% of MS patients complain of fatigue, which is the most important factor in reducing individual independence and the quality of life, and may cause a lack of participation in physical activities (
12). This may threaten the independence and the ability of the individual to effectively participate in the community, and have significant effects on their overall health and quality of life (
13).
During the past decade, the concept of health-related quality of life has attracted a lot of attention, and great effort has been made to assess its quality and quantity. The quality of life is the perception and personal experience of health and illness (
14), which may present a multi-dimensional structure of the various dimensions of the functional, social, physical, emotional, and spiritual formation of the subject. Previous studies have shown the negative effects of MS on the quality of life of the affected patients (
1). The general purpose of MS treatment is to decrease the negative impacts of this disease on the yield and quality of life of the patient. Overall, improving the quality of life is the most important step to control this disease.
A quality of life assessment in MS patients takes into account more than the nervous system aspect of the disease (
3). Several studies have been done on the quality of life in MS patients, and their results have shown that the symptoms, including depression, pain, and fatigue, have a negative influence on the patient’s quality of life (
15), causing a reduction in the quality of life in these patients (
1). These studies have shown a lower level in the quality of life of MS patients in terms of their physical and mental health, independence, social relationships, and satisfaction with their environments, when compared with the normal groups (
5). In addition, higher levels of depression and fatigue in patients with MS were observed, when compared to the healthy subjects (
2). Reports have shown that factors such as the age, education level, duration and type of the disease (
6), and physical disability affect the quality of life (
3). However, the predicted factors of life quality in Iranian MS patients is not clear, and there has been less study on the effects of fatigue, mobility, and disability on the quality of life in this community.